LingVo.club
📖+40 XP
🎧+25 XP
+45 XP
More precise DNA editing could help cystic fibrosis — Level B2 — a woman sitting in front of a computer monitor

More precise DNA editing could help cystic fibrosisCEFR B2

27 Feb 2026

Adapted from Silvia Cernea Clark-Rice, Futurity CC BY 4.0

Photo by CDC, Unsplash

Level B2 – Upper-intermediate
5 min
290 words

Scientists have refined a DNA base-editing tool to increase precision and reduce harmful off-target changes. Base-pair editors combine a component that recognises a genome sequence with an enzyme that modifies DNA; these parts are connected by a molecular linker. Earlier editors, including one the group devised in 2020, could edit single cytosines but had trouble when multiple cytosines clustered in patterns such as "CC…CC." Among the tens of thousands of disease-causing C-to-T and T-to-C mutations that this editor type could target, three-quarters involve such clustered cytosines.

The researchers adjusted the linker and weakened the editor's binding to DNA, which reduced its activity on neighbouring bases. In human cell experiments the redesigned editor cut unintended bystander edits dramatically: the most accurate variant decreased bystander mutations by more than 80% while maintaining strong correction at the intended site. At several cystic fibrosis-related genetic sites, unintended edits fell from as high as 50–60% to less than 1% while largely preserving the desired change.

Because cystic fibrosis is caused by mutations in a gene that controls salt and water movement in lung cells, precise single-letter repair could produce longer-lasting benefits than daily drugs. Existing treatments, such as Trikafta, have improved life for many patients but require daily use and can be very costly. The work is still preclinical, but more precise base editors could help make accurate cellular models of rare variants, test drugs and enable more personalised genetic medicine.

  • Create accurate cell models of rare variants
  • Test potential drugs on those models
  • Support more personalised genetic medicine

The research was supported by the National Institutes of Health, the National Science Foundation and the Cystic Fibrosis Foundation. Source: Rice University.

Difficult words

  • precisionhigh degree of accuracy in a measurement or process
  • off-targetchange that affects unintentional sites in DNA
  • linkermolecule that connects two other molecules together
  • cytosineone of the four DNA bases, shown as letter C
    cytosines
  • bystander editan unintended DNA change near the target site
    bystander edits
  • preclinicalstage of research before testing treatments in humans
  • personaliseddesigned to match a specific person's genetic profile

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • How might more precise base editors change treatment options for diseases like cystic fibrosis? Give reasons.
  • What are the possible benefits and risks of more personalised genetic medicine using precise base editing?
  • How could accurate cell models of rare variants help researchers test new drugs or understand disease?

Related articles

Tofersen slows a rare form of ALS — Level B2
26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.